Puma Biotechnology Inc (PBYI)
4.76
-0.07
(-1.45%)
USD |
NASDAQ |
Apr 25, 10:32
Puma Biotechnology Market Cap: 229.47M for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 24, 2024 | 232.84M |
| April 23, 2024 | 247.30M |
| April 22, 2024 | 249.23M |
| April 19, 2024 | 241.52M |
| April 18, 2024 | 240.55M |
| April 17, 2024 | 249.23M |
| April 16, 2024 | 245.86M |
| April 15, 2024 | 257.91M |
| April 12, 2024 | 254.05M |
| April 11, 2024 | 264.66M |
| April 10, 2024 | 266.34M |
| April 09, 2024 | 281.05M |
| April 08, 2024 | 271.41M |
| April 05, 2024 | 272.85M |
| April 04, 2024 | 265.62M |
| April 03, 2024 | 257.91M |
| April 02, 2024 | 254.53M |
| April 01, 2024 | 254.53M |
| March 28, 2024 | 255.50M |
| March 27, 2024 | 269.00M |
| March 26, 2024 | 269.96M |
| March 25, 2024 | 269.48M |
| March 22, 2024 | 256.94M |
| March 21, 2024 | 257.91M |
| March 20, 2024 | 226.33M |
| Date | Value |
|---|---|
| March 19, 2024 | 207.29M |
| March 18, 2024 | 224.65M |
| March 15, 2024 | 241.04M |
| March 14, 2024 | 251.64M |
| March 13, 2024 | 256.94M |
| March 12, 2024 | 257.91M |
| March 11, 2024 | 264.66M |
| March 08, 2024 | 257.91M |
| March 07, 2024 | 277.19M |
| March 06, 2024 | 266.59M |
| March 05, 2024 | 249.71M |
| March 04, 2024 | 258.39M |
| March 01, 2024 | 283.94M |
| February 29, 2024 | 299.85M |
| February 28, 2024 | 318.17M |
| February 27, 2024 | 311.42M |
| February 26, 2024 | 312.38M |
| February 23, 2024 | 312.09M |
| February 22, 2024 | 281.59M |
| February 21, 2024 | 310.18M |
| February 20, 2024 | 323.52M |
| February 16, 2024 | 338.77M |
| February 15, 2024 | 333.05M |
| February 14, 2024 | 352.59M |
| February 13, 2024 | 295.89M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
73.76M
Minimum
May 11 2022
1.297B
Maximum
Apr 25 2019
284.51M
Average
266.47M
Median
Market Cap Benchmarks
| ADMA Biologics Inc | 1.456B |
| Regeneron Pharmaceuticals Inc | 97.01B |
| Sarepta Therapeutics Inc | 11.61B |
| CytomX Therapeutics Inc | 109.71M |
| Mirum Pharmaceuticals Inc | 1.103B |
Market Cap Related Metrics
| PE Ratio | 10.58 |
| PS Ratio | 0.9605 |
| Price to Book Value | 4.294 |
| Price to Free Cash Flow | 15.75 |
| Price | 4.76 |
| Earnings Yield | 9.45% |
| Operating PE Ratio | 6.804 |
| Normalized PE Ratio | 10.29 |